4. MRI-targeted biopsy identified more high-risk cancers and fewer clinically insignificant tumors. “MRI-Targeted or Standard Biopsy for Prostate-Cancer Diagnosis”, NEJM 参考资料: 1. Case 35-2021: A 50-Year-Old Woman with Pain in the Left Upper Quadrant and Hypoxemia 2. 病例35-2021——一...
MRI-targeted or standard biopsy for prostate-cancer diagnosis. N Engl J Med. 2018;378:1767- 77. CrossrefKasivisvanathan V, Rannikko AS, Borghi M, Panebianco V, Mynderse LA, Vaarala MH, et al. MRI-targeted or standard biopsy for prostate-cancer diagnosis. N Engl J Med 2018;378: ...
MRI-targeted or standard biopsy for prostate-cancer diagnosis. N Engl J Med 2018;378:1767-77. http://dx.doi.org/10.1056/NEJMoa1801993.KASIVISVANATHAN, V., RANNIKKO, A., BORGHI, M. et. al., MRI- Targeted or Standard Biopsy for Prostate-Cancer Diagnosis, N Engl J Med 2018, pp. ...
Active surveillance is a growing alternative option for patients with documented low-volume, low-grade prostate cancer. With recent advances in software and hardware of MRI, multiparametric MRI of the prostate has been shown to improve the accuracy in detecting and characterizing clinically significant ...
Multiparametric MRI combines anatomical MRI sequences with functional sequences to find lesions within the prostate that are suspicious of cancer. These lesions or regions of interest (ROIs) can then be biopsied in an MRI-targeted biopsy approach. Compared to TRUS-guided biopsy, this strategy ...
MRI Improves Prostate Cancer Biopsy Accuracy, Study Finds; New Technology Spots More Aggressive Cancer, but Fewer Low-Risk CasesThompson, Dennis
Multiparametric MRI (mpMRI) and MRI/transrectal-ultrasonography (TRUS)-guided fusion biopsy could improve detection of clinically significant prostate cancer in men with previous negative biopsy findings. A study published in BJU International prospectively enrolled men with elevated or rising PSA and/or...
Prostate Cancer Update 2019: Is MRI Imaging Replacing Biopsy? Naturopathic Doctor News & ReviewTAMBURRI, PHRANQ D.
It has been shown that obtaining more than 12 systematic tissue cores does not result in a significantly better cancer detection rate, but more adverse events [18, 19]. Suspicious areas on mpMRI can be targeted with MRI/TRUS fusion biopsy, percutaneous biopsy during MRI, or TRUS biopsy with...
PSMA-guided biopsies were carried out in a cognitive/fusion manner for all the recruited patients with or without MRI-guided biopsies and/or standard biopsy (SB). PCa and clinical significant PCa (csPCA) detection rate (DR) at prostate biopsy was assessed. Uni- and multivariable models were ...